Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
36
NCT01983514
Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Healthy Adults
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 31, 2013
Completion: Feb 28, 2014
NCT02414503
Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Adults With Autism Spectrum Disorder
Phase: Phase 1/2
Start: Apr 30, 2015
Completion: Feb 29, 2016